NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
This grant opportunity is for clinical trials that can be conducted at one or multiple sites. Applicants must be prepared to start the trial within the first quarter of the project's timeline. Before receiving the award, applicants need to have regulatory approvals (FDA, DSMB, IRB), drug supplies (including placebo if needed), and any necessary third-party agreements in place. If applicants ne…
The objective of this funding opportunity (NOFO) is to support the implementation of Phase I investigator-initiated single or multi-site clinical trials for diagnostic and/or therapeutic interventions (e.g., drugs, devices, and biologics, including cells and cell products) for heart, lung, blood…
Funding Source
Awards & funding
Eligibility
Foreign/Non-domestic (non-U.S.) entities (Foreign Organizations) are NOT eligible to apply. However, non-domestic (non-U.S.) components of U.S. organizations are eligible to apply, and foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Required registrations (…
Dates
Supporting links
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers